Cargando…

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement

The prevalence of allergic diseases is increasing globally, most particularly in middle- to low-income countries. This article examines the burden of allergic rhinitis and chronic urticaria in the Asia-Pacific region, unmet clinical needs, and the potential role of bilastine in the management of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mösges, Ralph, Lee, Dennis Lip Yen, Abong, Jovilia, Siasoco, Bella, Chow, Steven KW, Leong, Jern-Lin, Singh, Harvinder, Kuljit, S, Campomanes, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731482/
https://www.ncbi.nlm.nih.gov/pubmed/26844221
http://dx.doi.org/10.5415/apallergy.2016.6.1.56
_version_ 1782412550522011648
author Mösges, Ralph
Lee, Dennis Lip Yen
Abong, Jovilia
Siasoco, Bella
Chow, Steven KW
Leong, Jern-Lin
Singh, Harvinder
Kuljit, S
Campomanes, Benjamin
author_facet Mösges, Ralph
Lee, Dennis Lip Yen
Abong, Jovilia
Siasoco, Bella
Chow, Steven KW
Leong, Jern-Lin
Singh, Harvinder
Kuljit, S
Campomanes, Benjamin
author_sort Mösges, Ralph
collection PubMed
description The prevalence of allergic diseases is increasing globally, most particularly in middle- to low-income countries. This article examines the burden of allergic rhinitis and chronic urticaria in the Asia-Pacific region, unmet clinical needs, and the potential role of bilastine in the management of these conditions. An International Advisory Group meeting was convened in association with the Asian Pacific Society of Respirology Annual Congress in November 2014, followed by a literature review, and consensus-based outcomes from the meeting and literature review are described. Regional estimates of the prevalence of allergic rhinitis range from 10% to 50%, while little is known regarding the burden of urticaria in the Asia-Pacific region. A survey of allergy patients in the region identified fast, complete, and long-lasting symptom relief as the medication attributes most important to patients. International treatment guidelines for allergic rhinitis and urticaria advocate the first-line use of second-generation, no-sedating H1-antihistamines, such as bilastine, over their first-generation counterparts and a range of these agents are available to Asia-Pacific patients. The newer agents possess many of the properties of an "ideal" antihistamine (once daily administration, rapid and complete symptom relief, limited potential for drug-drug interactions, minimal side effects). The burgeoning prevalence of allergic diseases in the Asia-Pacific region and the uncontrolled symptoms that these patients experience demand a new antihistamine that offers the highest number of positive features according to the international guidelines.
format Online
Article
Text
id pubmed-4731482
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Asia Pacific Association of Allergy, Asthma and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-47314822016-02-03 Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement Mösges, Ralph Lee, Dennis Lip Yen Abong, Jovilia Siasoco, Bella Chow, Steven KW Leong, Jern-Lin Singh, Harvinder Kuljit, S Campomanes, Benjamin Asia Pac Allergy Hypothesis & Experience The prevalence of allergic diseases is increasing globally, most particularly in middle- to low-income countries. This article examines the burden of allergic rhinitis and chronic urticaria in the Asia-Pacific region, unmet clinical needs, and the potential role of bilastine in the management of these conditions. An International Advisory Group meeting was convened in association with the Asian Pacific Society of Respirology Annual Congress in November 2014, followed by a literature review, and consensus-based outcomes from the meeting and literature review are described. Regional estimates of the prevalence of allergic rhinitis range from 10% to 50%, while little is known regarding the burden of urticaria in the Asia-Pacific region. A survey of allergy patients in the region identified fast, complete, and long-lasting symptom relief as the medication attributes most important to patients. International treatment guidelines for allergic rhinitis and urticaria advocate the first-line use of second-generation, no-sedating H1-antihistamines, such as bilastine, over their first-generation counterparts and a range of these agents are available to Asia-Pacific patients. The newer agents possess many of the properties of an "ideal" antihistamine (once daily administration, rapid and complete symptom relief, limited potential for drug-drug interactions, minimal side effects). The burgeoning prevalence of allergic diseases in the Asia-Pacific region and the uncontrolled symptoms that these patients experience demand a new antihistamine that offers the highest number of positive features according to the international guidelines. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2016-01 2016-01-27 /pmc/articles/PMC4731482/ /pubmed/26844221 http://dx.doi.org/10.5415/apallergy.2016.6.1.56 Text en Copyright © 2016. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hypothesis & Experience
Mösges, Ralph
Lee, Dennis Lip Yen
Abong, Jovilia
Siasoco, Bella
Chow, Steven KW
Leong, Jern-Lin
Singh, Harvinder
Kuljit, S
Campomanes, Benjamin
Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
title Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
title_full Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
title_fullStr Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
title_full_unstemmed Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
title_short Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
title_sort role of bilastine in the management of allergic rhinitis and urticaria: an asia-pacific consensus statement
topic Hypothesis & Experience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731482/
https://www.ncbi.nlm.nih.gov/pubmed/26844221
http://dx.doi.org/10.5415/apallergy.2016.6.1.56
work_keys_str_mv AT mosgesralph roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT leedennislipyen roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT abongjovilia roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT siasocobella roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT chowstevenkw roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT leongjernlin roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT singhharvinder roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT kuljits roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement
AT campomanesbenjamin roleofbilastineinthemanagementofallergicrhinitisandurticariaanasiapacificconsensusstatement